Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# Concours
Philadelphia, PA 19104Phone+1 215-662-2428
Summary
- Dr. William Levin is a radiation oncologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. He received his medical degree from Tel Aviv University Sackler and has been in practice 19 years. He specializes in sarcoma and thoracic cancer and is experienced in lung cancer, sarcomas, and medical director, global network operations.
Education & Training
- Massachusetts Gen Hosp2003 - 2005
- University of Pennsylvania Health SystemResidency, Radiation Oncology, 1999 - 2003
- Yale-New Haven Medical CenterInternship, Internal Medicine, 1998 - 1999
- Tel Aviv University SacklerClass of 1998
Certifications & Licensure
- NJ State Medical License 2008 - 2025
- PA State Medical License 2000 - 2024
- MD State Medical License 2005 - 2008
- MA State Medical License 2003 - 2005
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.Michelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, Xingmei Wang, Timothy Kegelman
Cancer. 2024-06-01 - 2 citationsPhase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer.Nikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, Cole Friedes, Eva Berlin
International Journal of Radiation Oncology, Biology, Physics. 2024-05-01 - 1 citationsPlunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidat...Adam Barsouk, Cole Friedes, Michelle Iocolano, Abigail Doucette, Roger B Cohen
Clinical Lung Cancer. 2024-05-01
Press Mentions
- Easing Patient Fears of Radiation Treatment, via Virtual RealityOctober 24th, 2024
- Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation TherapyAugust 18th, 2022
- Rocket VR Health and Penn Medicine Partner to Test HeadsetAugust 18th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: